Abstract
Edible berry extracts rich in anthocyanins possess a broad spectrum of therapeutic, pharmacologic and anti-carcinogenic properties. Six berry extracts (wild blueberry, bilberry, cranberry, elderberry, raspberry seeds and strawberry), singly and in combination, were studied in our laboratories for antioxidant efficacy, cytotoxic potential, cellular uptake and anti-angiogenic properties. Combinations of edible berry extracts were evaluated to develop a synergistic formula, OptiBerry, which exhibited high oxygen radical absorbance capacity (ORAC) value, low cytotoxicity and superior anti-angiogenic properties compared to the other combinations tested. The current study sought to determine the broad spectrum safety and antioxidant potential of OptiBerry in vivo. Acute oral LD50 of OptiBerry was greater than 5 g/kg in rats. Acute dermal LD50 of OptiBerry was greater than 2 g/kg. No changes in the body weight or adverse effects were observed following necropsy. Primary skin and eye irritation studies were conducted in New Zealand albino rabbits. OptiBerry was classified as slightly irritating to the skin (primary skin irritation index 0.3) and minimally irritating to the eye (maximum mean total score 6.0). The antioxidant potential of OptiBerry was investigated in rats and mice by assessing GSH redox status in tissues as well as by a unique state-of-the-art electron paramagnetic resonance (EPR) imaging of whole-body redox status. A clinically relevant hyperbaric oxygen (HBO) exposure system (2 atm, 2 h) was employed to study the antioxidant properties of OptiBerry. OptiBerry feeding (8 weeks) significantly prevented HBO-induced GSH oxidation in the lung and liver of vitamin E-deficient Sprague Dawley rats. Furthermore, OptiBerry-fed mice, when exposed to HBO, demonstrated significant protection in whole-body HBO-induced oxidation compared to the unfed controls by EPR imaging. Taken together, these results indicate that OptiBerry is reasonably safe and possess antioxidant properties.
Similar content being viewed by others
References
Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N: Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. New Engl J Med 324: 1599, 1991
Colic M, Pavelic K: Molecular mechanisms of anticancer activity of natural dietetic products. J Mol Med 78: 333–336, 2000
Kresty LA, Morse MA, Morgan C, Carlton PS, Lu L, Gupta A, Blackwood M, Stoner GD: Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61: 6112–6119, 2001
McCarty MF: Current prospects for controlling cancer growth with non-cytotoxic agents – nutrients, phytochemicals, herbal extracts, and available drugs. Med Hypotheses 56: 137–154, 2001
She QB, Bode AM, Ma WY, Chen NY, Dong Z: Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61: 1604–1610, 2001
Xue H, Aziz RM, Sun N, Cassady JM, Kamendulis LM, Xu Y, Stoner GD, Klaunig JE: Inhibition of cellular transformation by berry extracts. [erratum appears in Carcinogenesis 22 (2001) 831–833]; Carcinogenesis 22: 351–356, 2001
Cao G, Prior RL: Anthocyanins are detected in human plasma after oral administration of an elderberry extract. Clin Chem 45: 574–576, 1999
Giavazzi R, Taraboletti G: Angiogenesis and angiogenesis inhibitors in cancer. Forum 9: 261–272, 1999
Griffioen AW, Molema G: Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52: 237–268, 2000
Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L: Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57: 2916–2921, 1997
Fotsis T, Pepper MS, Montesano R, Aktas E, Breit S, Schweigerer L, Rasku S, Wahala K, Adlercreutz H: Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metabol 12: 649–666, 1998
Hayashi A, Gillen AC, Lott JR: Effects of daily oral administration of quercetin chalcone and modified citrus pectin. Altern Med Rev 5: 546–552, 2000
Hisa T, Kimura Y, Takada K, Suzuki F, Takigawa M: Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro. Anticancer Res 18: 783–790, 1998
Jiang C, Agarwal R, Lu J: Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: Inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. Biochem Biophys Res Commun 276: 371–378, 2000
Paper DH: Natural products as angiogenesis inhibitors. Planta Medica 64: 686–695, 1998
Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK: Anti-angiogenic property of edible berries. Free Radic Res 36: 1023–1031, 2002
Gordillo G, Onat D, Stockinger M, Roy S, Atalay M, Beck F, Sen C: A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation. Am J Physiol Cell Physiol 287: C866–C873, 2004
Gordillo GM, Atalay M, Roy S, Sen CK: Hemangioma model for in vivo angiogenesis: inducible oxidative stress and MCP-1 expression in EOMA cells. Methods Enzymol 352: 422–432, 2002
Atalay M, Gordillo G, Roy S, Rovin B, Bagchi D, Bagchi M, Sen CK: Anti-angiogenic property of edible berry in a model of hemangioma. FEBS Lett 544: 252–257, 2003
Knight J: Safety concerns prompt US ban on dietary supplement. Nature 427: 90, 2004
Kahkonen MP, Hopia AI, Heinonen M: Berry phenolics and their antioxidant activity. J Agric Food Chem 49: 4076–4082, 2001
Speit G, Dennog C, Radermacher P, Rothfuss A: Genotoxicity of hyperbaric oxygen. Mutation Res 512: 111–119, 2002
Draize J, Woodward G, Calvary H: Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82: 377–390, 1944
Draize J: The appraisal of the safety of chemicals in foods. In: Drugs and Cosmetics. Dermal Toxicity, Association of Food and Drug Officials of the US, Topeka, KA, 1965, pp 46–59
Kay J, Calandra J: Interpretation of eye irritation tests. J Soc Cos Chem 13: 281–289, 1962
Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, Roy S: Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem 277: 33284–33290, 2002
Roy S, Venojarvi M, Khanna S, Sen CK: Simultaneous detection of tocopherols and tocotrienols in biological samples using HPLC-coulometric electrode array. Methods Enzymol 352: 326–332, 2002
Khanna S, Roy S, Ryu H, Bahadduri P, Swaan PW, Ratan RR, Sen CK: Molecular basis of vitamin E action: Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem 278: 43508–43515, 2003
He G, Shankar RA, Chzhan M, Samouilov A, Kuppusamy P, Zweier JL: Noninvasive instrument of anatomic structure and intraluminal oxygenation in the gastrointestinal tract of living mice with spatial and spectral EPR imaging. Proc Natl Acad Sci USA 96: 4586–4591, 1999
He G, Petryakov S, Samouilov A, Chzhan M, Kuppusamy P, Zweier J: Development of a resonator with automatic tuning and coupling capability to minimize sample motion noise for in vivo EPR spectroscopy. J Magn Reson 149: 218–227, 2001
Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S: Oxygen, oxidants, and antioxidants in wound healing: An emerging paradigm. Ann NY Acad Sci 957: 239–249, 2002
Gordillo GM, Sen CK: Revisiting the essential role of oxygen in wound healing. Am J Surg 186: 259–263, 2003
Wu G, Fang YZ, Yang S, Lupton JR, Turner ND: Glutathione metabolism and its implications for health. J Nutr 134: 489–492, 2004
White CW, Mimmack RF, Repine JE: Accumulation of lung tissue oxidized glutathione (GSSG) as a marker of oxidant induced lung injury. Chest 89: 111S–113S, 1986
Jenkinson SG, Marcum RF, Pickard JS, Orzechowski Z, Lawrence RA, Jordan JM: Glutathione disulfide formation occurring during hypoxia and reoxygenation of rat lung. J Lab Clin Med 112: 471–480, 1988
Hammerschmidt S, Buchler N, Wahn H: Tissue lipid peroxidation and reduced glutathione depletion in hypochlorite-induced lung injury. Chest 121: 573–581, 2002
Ookhtens M, Kaplowitz N: Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis 18: 313–329, 1998
Jaeschke H: Glutathione disulfide as index of oxidant stress in rat liver during hypoxia. Am J Physiol 258: G499–G505, 1990
Mandl J, Banhegyi G: Role of glutathione in the regulation of liver metabolism. Biofactors 17: 21–26, 2003
Yamauchi A, Tsuyuki S, Inamoto T, Yamaoka Y: Liver immunity and glutathione. Antioxid Redox Signal 1: 245–253, 1999
He G, Kumar Kutala V, Kuppusamy P, Zweier JL: In vivo measurement and mapping of skin redox stress induced by ultraviolet light exposure. Free Radic Biol Med 36: 665–672, 2004
He G, Samouilov A, Kuppusamy P, Zweier JL: In vivo imaging of free radicals: applications from mouse to man. Mol Cell Biochem 234–235: 359–367, 2002
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bagchi, D., Roy, S., Patel, V. et al. Safety and whole-body antioxidant potential of a novel anthocyanin-rich formulation of edible berries. Mol Cell Biochem 281, 197–209 (2006). https://doi.org/10.1007/s11010-006-1030-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-006-1030-6